|
|
|
|
|
|
|
||
The Journal of General Physiology, Vol 105, 745-764, Copyright © 1995 by The Rockefeller University Press
ARTICLES |
BN Cohen, A Figl, MW Quick, C Labarca, N Davidson and HA Lester
Division of Biomedical Sciences, University of California, Riverside 92521-0121, USA.
We constructed chimeras of the rat beta 2 and beta 4 neuronal nicotinic subunits to locate the regions that contribute to differences between the acetylcholine (ACh) dose-response relationships of the alpha 3 beta 2 and alpha 3 beta 4 receptors. Expressed in Xenopus oocytes, the alpha 3 beta 2 receptor displays an EC50 for ACh approximately 20-fold less than the EC50 of the alpha 3 beta 4 receptor. The apparent Hill slope (n(app)) of alpha 3 beta 2 is near one whereas the alpha 3 beta 4 receptor displays an n(app) near two. Substitutions within the first 120 residues convert the EC50 for ACh from one wild-type value to the other. Exchanging just beta 2:104-120 for the corresponding region of beta 4 shifts the EC50 of ACh dose-response relationship in the expected direction but does not completely convert the EC50 of the dose- response relationship from one wild-type value to the other. However, substitutions in the beta 2:104-120 region do account for the relative sensitivity of the alpha 3 beta 2 receptor to cytisine, tetramethylammonium, and ACh. The expression of beta 4-like (strong) cooperativity requires an extensive region of beta 4 (beta 4:1-301). Relatively short beta 2 substitutions (beta 2:104-120) can reduce cooperativity to beta 2-like values. The results suggest that amino acids within the first 120 residues of beta 2 and the corresponding region of beta 4 contribute to an agonist binding site that bridges the alpha and beta subunits in neuronal nicotinic receptors.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  C. Fonck, B. N. Cohen, R. Nashmi, P. Whiteaker, D. A. Wagenaar, N. Rodrigues-Pinguet, P. Deshpande, S. McKinney, S. Kwoh, J. Munoz, et al. Novel Seizure Phenotype and Sleep Disruptions in Knock-In Mice with Hypersensitive {alpha}4* Nicotinic Receptors J. Neurosci., December 7, 2005; 25(49): 11396 - 11411. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. O. Rodrigues-Pinguet, T. J. Pinguet, A. Figl, H. A. Lester, and B. N. Cohen Mutations Linked to Autosomal Dominant Nocturnal Frontal Lobe Epilepsy Affect Allosteric Ca2+ Activation of the {alpha}4{beta}2 Nicotinic Acetylcholine Receptor Mol. Pharmacol., August 1, 2005; 68(2): 487 - 501. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. A. Jensen, I. Mikkelsen, B. Frolund, H. Brauner-Osborne, E. Falch, and P. Krogsgaard-Larsen Carbamoylcholine Homologs: Novel and Potent Agonists at Neuronal Nicotinic Acetylcholine Receptors Mol. Pharmacol., October 1, 2003; 64(4): 865 - 875. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Zhou, J. Ren, E. Brown, D. Schneider, Y. Caraballo-Lopez, and J. J. Galligan Pharmacological Properties of Nicotinic Acetylcholine Receptors Expressed by Guinea Pig Small Intestinal Myenteric Neurons J. Pharmacol. Exp. Ther., September 1, 2002; 302(3): 889 - 897. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Rush, A. Kuryatov, M. E. Nelson, and J. Lindstrom First and Second Transmembrane Segments of alpha 3, alpha 4, beta 2, and beta 4 Nicotinic Acetylcholine Receptor Subunits Influence the Efficacy and Potency of Nicotine Mol. Pharmacol., June 1, 2002; 61(6): 1416 - 1422. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Le Novere, T. Grutter, and J.-P. Changeux Models of the extracellular domain of the nicotinic receptors and of agonist- and Ca2+-binding sites PNAS, February 20, 2002; (2002) 42699699. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Parker, S. C. Harvey, and C. W. Luetje Determinants of Agonist Binding Affinity on Neuronal Nicotinic Receptor beta Subunits J. Pharmacol. Exp. Ther., October 1, 2001; 299(1): 385 - 391. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. A. Schneider and J. J. Galligan Presynaptic nicotinic acetylcholine receptors in the myenteric plexus of guinea pig intestine Am J Physiol Gastrointest Liver Physiol, September 1, 2000; 279(3): G528 - G535. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. M. Francis, R. W. Vazquez, R. L. Papke, and R. E. Oswald Subtype-Selective Inhibition of Neuronal Nicotinic Acetylcholine Receptors by Cocaine Is Determined by the alpha 4 and beta 4 Subunits Mol. Pharmacol., July 1, 2000; 58(1): 109 - 119. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. M. Levandoski, Y. Lin, L. Moise, J. T. McLaughlin, E. Cooper, and E. Hawrot Chimeric Analysis of a Neuronal Nicotinic Acetylcholine Receptor Reveals Amino Acids Conferring Sensitivity to alpha -Bungarotoxin J. Biol. Chem., September 10, 1999; 274(37): 26113 - 26119. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Wang, M. E. Nelson, A. Kuryatov, F. Olale, J. Cooper, K. Keyser, and J. Lindstrom Chronic Nicotine Treatment Up-regulates Human alpha 3beta 2 but Not alpha 3beta 4 Acetylcholine Receptors Stably Transfected in Human Embryonic Kidney Cells J. Biol. Chem., October 30, 1998; 273(44): 28721 - 28732. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. A. Stafford, R. E. Oswald, A. Figl, B. N. Cohen, and G. A. Weiland Two Domains of the Beta Subunit of Neuronal Nicotinic Acetylcholine Receptors Contribute to the Affinity of Substance P J. Pharmacol. Exp. Ther., August 1, 1998; 286(2): 619 - 626. [Abstract] [Full Text]
|
|
|
|
|
|
R. Zwart and H. P. M. Vijverberg Potentiation and Inhibition of Neuronal Nicotinic Receptors by Atropine: Competitive and Noncompetitive Effects Mol. Pharmacol., November 1, 1997; 52(5): 886 - 895. [Abstract] [Full Text]
|
|
|
|
|
|
C. P. Fenster, M. F. Rains, B. Noerager, M. W. Quick, and R. A. J. Lester Influence of Subunit Composition on Desensitization of Neuronal Acetylcholine Receptors at Low Concentrations of Nicotine J. Neurosci., August 1, 1997; 17(15): 5747 - 5759. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. C. Harvey, J. M. Mcintosh, G. E. Cartier, F. N. Maddox, and C. W. Luetje Determinants of Specificity for alpha -Conotoxin MII on alpha 3beta 2 Neuronal Nicotinic Receptors Mol. Pharmacol., February 1, 1997; 51(2): 336 - 342. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. E. Chavez-Noriega, J. H. Crona, M. S. Washburn, A. Urrutia, K. J. Elliott, and E. C. Johnson Pharmacological Characterization of Recombinant Human Neuronal Nicotinic Acetylcholine Receptors halpha 2beta 2, halpha 2beta 4, halpha 3beta 2, halpha 3beta 4, halpha 4beta 2, halpha 4beta 4 and halpha 7 Expressed in Xenopus Oocytes J. Pharmacol. Exp. Ther., January 1, 1997; 280(1): 346 - 356. [Abstract] [Full Text]
|
|
|
|
|
|
S. C. Harvey and C. W. Luetje Determinants of Competitive Antagonist Sensitivity on Neuronal Nicotinic Receptor beta Subunits J. Neurosci., June 15, 1996; 16(12): 3798 - 3806. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Le Novere, T. Grutter, and J.-P. Changeux Models of the extracellular domain of the nicotinic receptors and of agonist- and Ca2+-binding sites PNAS, March 5, 2002; 99(5): 3210 - 3215. [Abstract] [Full Text] [PDF]
|
|
|
|
